Psychiatry and Neurology, Neurology · Audubon, NJ
NPI
1962591586
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
739 S. White Horse Pike, Suite 1
Audubon, NJ, 08106
Phone (856) 546-2300
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.2M
115,614 services
Medicare patients, 2024
500
Average age 71
Drug cost, 2024
$5.6M
2,821 prescriptions
Company payments, 2025
$211K
From 42 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven M Bromley was code J2350 (injection, ocrelizumab, 1 mg), 39,001 times for 39 patients. In total Steven M Bromley billed 115,614 services in 41 codes, and Medicare paid $3.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-06-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2350 Injection, ocrelizumab, 1 mg | Office | 39,001 | 39 | $42.42 | $1.7M |
| J3032 Injection, eptinezumab-jjmr, 1 mg | Office | 27,100 | 26 | $14.40 | $390K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 10,034 | 56 | $0.23 | $2,343 |
| J1459 Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 9,710 | 14 | $37.72 | $366K |
| J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Office | 6,390 | 13 | $38.44 | $246K |
| 96366 Intravenous Infusion, Hydration | Office | 646 | 30 | $17.96 | $12K |
| 99215 Office E&M - Established | Office | 536 | 325 | $146.13 | $78K |
| 96365 Intravenous Infusion, Hydration | Office | 494 | 72 | $54.77 | $27K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 325 | 56 | $0.50 | $162 |
| 99214 Office E&M - Established | Office | 260 | 205 | $99.39 | $26K |
| J2930 Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 191 | 24 | $3.60 | $687 |
| 96415 Chemotherapy Administration | Office | 146 | 40 | $24.84 | $3,626 |
| 99205 Office E&M - New | Office | 120 | 120 | $164.83 | $20K |
| 96413 Chemotherapy Administration | Office | 118 | 53 | $112.49 | $13K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 98 | 23 | $0.93 | $91.26 |
By year: 2022 $8.7M for 161,953 services; 2023 $5.7M for 121,252 services; 2024 $3.2M for 115,614 services.
Medicare prescription drug claims, 2024
In 2024, the drug Steven M Bromley prescribed most often to Medicare patients was Duloxetine Hcl, with 177 prescriptions and refills. In total Steven M Bromley wrote 2,821 Medicare prescriptions that cost $5.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Duloxetine Hcl Generic | 177 | 398 | 49 | $3,223 |
| Donepezil Hcl Generic | 162 | 373 | 58 | $3,748 |
| Gabapentin Generic | 139 | 311 | 49 | $2,862 |
| Baclofen Generic | 108 | 256 | 38 | $2,783 |
| Sertraline Hcl Generic | 89 | 141 | 23 | $1,114 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 77 | 201 | 26 | $3,109 |
| Memantine Hcl Generic | 77 | 167 | 32 | $2,121 |
| Dalfampridine Er Dalfampridine | 76 | 112 | 13 | $30K |
| Escitalopram Oxalate Generic | 72 | 152 | 25 | $1,096 |
| Botox Onabotulinumtoxina | 62 | 185 | 28 | $89K |
| Clonazepam Generic | 60 | 72 | 26 | $482 |
| Topiramate Generic | 59 | 134 | 17 | $974 |
| Quetiapine Fumarate Generic | 53 | 87 | 17 | $623 |
| Trazodone Hcl Generic | 51 | 103 | 18 | $456 |
| Propranolol Hcl Er Propranolol Hcl | 50 | 118 | 19 | $2,680 |
Brand drugs: - claims; generic drugs: 2,218 claims; opioid claims: 61.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven M Bromley $211K ($211K in general payments such as food, travel and fees) from 42 companies. The largest payer was Lilly USA, LLC with $52K.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 42 | $52K |
| EMD Serono, Inc. MRK.DE | 58 | $40K |
| UCB, Inc. UCB.BR | 48 | $37K |
| Abbvie Inc. ABBV | 117 | $24K |
| E.R. Squibb & Sons, L.L.C. BMY | 13 | $17K |
| Lundbeck LLC | 28 | $11K |
| ANI Pharmaceuticals, Inc. ANIP | 25 | $7,145 |
| Genentech USA, Inc. ROG.SW | 15 | $7,080 |
| Alexion Pharmaceuticals, Inc. AZN | 7 | $6,524 |
| Eisai Inc. 4523.T | 19 | $3,674 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.